跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 66,734 条关于
“high-sensitivity C-reactive protein”
全部
66,734
临床试验
40,789
药物
3,214
机构
3,267
资讯
19,464
去年
Ventyx Biosciences Advances NLRP3 Inhibitor Portfolio with Phase 2 Trials
11年前
Serum Free Light Chain Levels Predict Need for Future PCI in STEMI Patients
去年
Semaglutide Reduces Albuminuria in CKD Patients Without Diabetes
2年前
Orforglipron Shows Promise in Reducing Cardiovascular and Inflammatory Markers in Phase II Trial
10个月前
Ventyx Biosciences' VTX3232 Shows 78% Reduction in Key Inflammatory Marker in Phase II Trial
18天前
TRANQUILITY: Pacibekitug Produces Sustained Reductions in Inflammatory Markers in CKD Patients
去年
Novartis Acquires Tourmaline Bio for $1.4 Billion to Strengthen Cardiovascular Pipeline with Pacibekitug
去年
Tirzepatide Shows Promise in Phase III Trial for Heart Failure with Preserved Ejection Fraction
去年
Zealand Pharma's Petrelintide Enrolls First Participant in Phase 2b Obesity Trial
2年前
Semaglutide Shows Promise for Obesity-Related Heart Failure with Preserved Ejection Fraction
第 1 页,共 1947 页
上一页
下一页